 |
|
|
|
|
|
|
 |
|
|
For further information on
inVentiv Health, please contact us. |
|
| DAVE BASSIN |
| Chief Financial Officer |
| inVentiv Health |
|
| 732.537.4800 |
|
| investor@inventivhealth.com |
|
|
|
|
|
|
|
|
|
|
|
|
| inVentiv Health (NASDAQ: VTIV) is the leading provider of commercialization services to the global pharmaceutical and life sciences industries. inVentiv's employees support
over 325 client organizations, including all top 20 global pharmaceutical companies as well as emerging and specialty biotech leaders. |
|
| The inVentiv delivery model is flexible and client-focused, enabling the company to rapidly respond to changing client needs and market conditions with both integrated and independent programs. |
|
| inVentiv's
customized
clinical,
sales,
marketing
and
communications
services
are
organized
into
four key
business
segments:
inVentiv
Clinical,
inVentiv
Communications,
inVentiv
Commercial,
and
inVentiv
Patient
Outcomes: |
|
| inVentiv Clinical |
|
 |
Clinical Staffing |
|
|
Clinical Development |
|
|
Strategic Resource Groups |
|
|
Executive Placement |
|
| inVentiv Communications |
|
|
Advertising |
|
|
Branding |
|
|
Interactive Communication |
|
|
Medical Education |
|
|
Public Relations |
|
|
Direct Marketing |
|
|
Event Planning |
|
| inVentiv Commercial |
|
|
Strategic Planning |
|
|
Market Analytics & Research |
|
|
Marketing Segmentation |
|
|
Outsourced Marketing |
|
|
Managed Markets |
|
|
Sales Teams |
|
|
Training & Development |
|
|
Sales Recruitment |
|
|
Sample Management |
|
|
Sales Technology |
|
| inVentiv Patient Outcomes |
|
|
Patient Adherence |
|
|
Patient Assistance |
|
|
Clinical Educator Teams |
|
|
Disease Management |
|
|
|
In 2007,
inVentiv
reported
revenues
of $977
million,
which
represents
an
increase
of 28%
from
2006
results,
and
adjusted
net
earnings
per
share
from
continuing
operations
of $1.59
(GAAP of
$1.46),
which
represents
an
increase
of 16%
over
2006
results
(GAAP
EPS down
11% due
to 2006
tax
benefits).
As of
December
31,
2007,
the
Company
had $1.1
billion
in total
assets,
including
$98
million
of cash
and
marketable
securities
on the
Balance
Sheet.
inVentiv
Health,
a
component
of the
Russell
3000 and
the S&P
SmallCap
600, is
listed
on the
NASDAQ
National
Market
under
the
symbol
"VTIV." |
|
|
|
|
|
|
